Announcements Trials

Browse Landscape

Phase

Status

Completed 5 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 18 Sarcoma 15 Burkitt Lymphoma 9 Breast Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Neoplasm Metastasis 8 Triple Negative Breast Neoplasms 7 Lymphoma, T-Cell, Peripheral 7 Lymphoma, Follicular 7 Lymphoma, B-Cell 7 Ovarian Neoplasms 6 Lymphoma 6 Hodgkin Disease 6 Endometrial Neoplasms 5 Osteosarcoma 4 Neuroblastoma 4 Lymphoma, Non-Hodgkin 4 Liposarcoma 4 Recurrence 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Peritoneal Neoplasms 3 Neoplasms 3 Leukemia, Biphenotypic, Acute 3 Leiomyosarcoma 3 Histiocytoma, Malignant Fibrous 3 Hemangiosarcoma 3 Colorectal Neoplasms 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Sarcoma, Synovial 2

Interventions

pembrolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 cemiplimab 2 camrelizumab 2 cabozantinib 2 apatinib 2 Mitotane 2 fludarabine phosphate 1 dostarlimab 1 Megestrol Acetate 1 Interleukin-13 1 Fluorodeoxyglucose F18 1 Floxuridine 1 Etoposide 1 Drug Therapy 1 Doxorubicin 1 Dexamethasone 1 Cyclophosphamide 1 Cisplatin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Adrenocortical Carcinoma × Doxorubicin × Clear all

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡